Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke

Thrombosis and Haemostasis

Volumn 107, Issue 2, 2012, Pages 346-355

  Lukasik, Maria ^a   Dworacki, Grzegorz ^a   Kufel Grabowska, Joanna ^a   Watala, Cezary ^b   Kozubski, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

CD40L; Leukocyte platelet aggregates; Prognostic factors; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND; CD45 ANTIGEN; CD61 ANTIGEN; PADGEM PROTEIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRANULOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANKIN SCALE; SCANDINAVIAN STROKE SCALE; SCORING SYSTEM; STROKE PATIENT; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PLATELETS; CD40 LIGAND; CELL AGGREGATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84856686739     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-05-0345     Document Type: Article

References (31)

1. Kazmierski R, Guzik P, Ambrosius W, et al. Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clin Neurol Neurosurg 2004; 107: 38-43.
2. Elkind MSV, Cheng J, Rundek T, et al. Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. J Stroke Cerebrovasc Dis 2004; 13: 220-227.
3. Grau AJ, Boddy AW, Dukovic DA, et al., for the CAPRIE Investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004; 35: 1147-1152.
4. Bath P, Algert C, Chapman N, et al. PROGRESS Collaborative Group. Associations of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622-626.
5. Michelson AD, Barnard MR, Hechtman H, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-11883.
6. Anand SX, Viles-Gonzalez JF, Badimon JJ, et al. Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb Haemost 2003; 90: 377-384.
7. Michelson AD, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533-1537.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
9. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526.
10. Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology 1995; 45: S4-10.
11. Garlichs CD, Kozina S, Fateh-Moghadam S, et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003; 34: 1412-1418.
12. McCabe DJH, Harrison P, Mackie IJ, et al. Platelet degranulation and monocyteplatelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004; 125: 777-787.
13. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001; 104: 503-516.
14. Yilmaz G, Granger DN. Leukocyte recruitment and ischemic brain injury. Neuromol Med 2010; 12: 193-204.
15. Barone FC, Hillegass LM, Tzimas MN, et al. Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. Mol Chem Neuropathol 1995; 24: 13-30.
16. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97: 1525-1534.
17. Fitzgerald GA. COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Dug Discov 2003; 2: 879-890.
18. Galt SW, Lindemann S, Medd D, et al. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 2008; 102: 302-309.
19. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001; 89: 1092-1103.
20. von Hundelshausen P, Weber KS, Huo Y, et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 1772-1777.
21. Dixon DA, Tolley ND, Bemis-Standoli K, et al. Expression of COX-2 in plateletmonocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest 2006; 95: 2297-2303.
22. Welsh P, Lowe GD, Chalmers J, et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 2008; 39: 2226-2230.
23. Ishikawa M, Cooper D, Russel J, et al. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 2003; 34: 1777-1782.
24. Li G, Sanders JM, Bevard MH, et al. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am J Pathol 2008, 172: 1141-1152.
25. Garlichs CD, Johm S, Schmeisser Y, et al. Upregulation of CD40-CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 2001, 104: 2395-2400.
26. Cipollone F, Ferri C, Desideri G, et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 2003, 108: 2776-2782.
27. Michelson AD, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533-1537.
28. Aslanyan S, Weir CJ, Diener HC, et al.; GAIN International Steering Committee and Investigators. Pneumonia and urinary tract infection after acute ischemic stroke: a tertiary analysis of the GAIN International Trial. Eur J Neurol 2004; 11: 49-53.
29. Urra X, Cervera A, Obach V, et al. Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke 2009; 40: 1262-1268.
30. Urra X, Villamor N, Amaro S, et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cerebr Blood Flow Metab 2009; 29: 994-1002.
31. Vargas M, Horcajada JP, Obach V, et al. Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 2006; 37: 461-465.